Pathology and Laboratory Medicine
459
Episodes 33-33 of 33
- CME/CE Broadcast Replay
Understanding the Biological and Clinical Rationale for PARP Inhibitor Combinations as Potential Treatment for Prostate Cancer
1.00 creditNeeraj Agarwal, MD, FASCO
- Previous
- Next